22 related articles for article (PubMed ID: 10718546)
1. Deleterious Mutations in the TPO Gene Associated with Familial Thyroid Follicular Cell Carcinoma in Dutch German Longhaired Pointers.
Yu Y; Bovenhuis H; Wu Z; Laport K; Groenen MAM; Crooijmans RPMA
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34209805
[TBL] [Abstract][Full Text] [Related]
2. Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.
Gan XX; Li YY; Li SJ; Mo SS; Feng JH; Shen F; Cai WS; Lai YQ; Xu B
Front Oncol; 2021; 11():680873. PubMed ID: 34422633
[TBL] [Abstract][Full Text] [Related]
3. The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer -- a long-term follow-up study.
Caballero Y; López-Tomassetti EM; Favre J; Santana JR; Cabrera JJ; Hernández JR
Thyroid Res; 2015; 8():12. PubMed ID: 26300979
[TBL] [Abstract][Full Text] [Related]
4. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.
de Micco C; Savchenko V; Giorgi R; Sebag F; Henry JF
Br J Cancer; 2008 Feb; 98(4):818-23. PubMed ID: 18212751
[TBL] [Abstract][Full Text] [Related]
5. Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.
Savin S; Cvejic D; Isic T; Petrovic I; Paunovic I; Tatic S; Havelka M
Endocr Pathol; 2006; 17(1):53-60. PubMed ID: 16760580
[TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer: a novel molecular marker?
Roddiger SJ; Renneberg H; Martin T; Tunn UW; Zamboglou N; Kurek R
J Cancer Res Clin Oncol; 2003 Jan; 129(1):29-34. PubMed ID: 12618898
[TBL] [Abstract][Full Text] [Related]
7. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
[TBL] [Abstract][Full Text] [Related]
10. Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?
Czarnocka B; Pastuszko D; Janota-Bzowski M; Weetman AP; Watson PF; Kemp EH; McIntosh RS; Asghar MS; Jarzab B; Gubala E; Wloch J; Lange D
Br J Cancer; 2001 Sep; 85(6):875-80. PubMed ID: 11556840
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues.
Umeki K; Tanaka T; Yamamoto I; Aratake Y; Kotani T; Sakamoto F; Noguchi S; Ohtaki S
Endocr J; 1996 Feb; 43(1):53-60. PubMed ID: 8732452
[TBL] [Abstract][Full Text] [Related]
12. Comparison of thyroid peroxidase expression with cellular proliferation in thyroid follicular tumors.
Garcia S; Vassko V; Henry JF; De Micco C
Thyroid; 1998 Sep; 8(9):745-9. PubMed ID: 9777743
[TBL] [Abstract][Full Text] [Related]
13. In situ hybridization and immunohistochemistry study of thyroid peroxidase expression in thyroid tumors.
De Micco C; Kopp F; Vassko V; Grino M
Thyroid; 2000 Feb; 10(2):109-15. PubMed ID: 10718546
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]